UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. (Q51533387)

6 April 2018

title

UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. (English)

1 reference

6 April 2018

1 reference

1 reference

1 reference

Ling Zhang

1

1 reference

6 April 2018

Xili Cao

2

1 reference

6 April 2018

Liqian Zhang

3

1 reference

6 April 2018

Xuelin Zhang

4

1 reference

6 April 2018

Haihui Sheng

5

1 reference

6 April 2018

Kun Tao

6

1 reference

6 April 2018

publication date

6 February 2016

1 reference

6 April 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

6 April 2018

volume

77

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

629-634

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s00280-016-2963-4

exact match

0 references

cites work

Targeted immune therapy of ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Global cancer statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Tuning in to the signals: noncoding sequence conservation in vertebrate genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Molecular mechanisms of long noncoding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Focusing on long noncoding RNA dysregulation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNAs and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNAs involved in cancer development and cell fate determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Aberrant expression of UCA1 in gastric cancer and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-2963-4

10.1007/S00280-016-2963-4

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

26851957

1 reference

6 April 2018